ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846
-A A +A
Has Profit Taken Precedence Over People?

Subramaniam vs Subramanian

The private assurances supposedly given by the Indian government to the United States-India Business Council that it would not grant compulsory licences to Indian drug makers for commercial purposes except in cases of public health emergencies negate the intent of the Indian intellectual policy regime to work patents in India and provide affordable medicines to people.



Subscribers please login to access full text of the article.

New 3 Month Subscription
to Digital Archives at

649for India

$20for overseas users

Get instant access to the complete EPW archives

Subscribe now

Comments

(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top